NCT00403130 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Phase II Gemzar, Taxol & Avastin Combination as 1st Line Tx for Metastatic Breast CA


Sponsors: Stanford University Genentech Eli Lilly and Company	Phases: Phase II
Indications	Acronym:
Breast Cancer
Age Groups: Adult Senior	Gender: Female
Names: Drug: Gemcitabine Drug: Paclitaxel Drug: Bevacizumab	Enrollment: 50

Additional information about NCT00403130.